Setting

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Published: 30 Sep 2022 | Report Code: 10248843 | Pages: 150

Europe single cell multiomics market was valued at $ 527.9 million in 2021 and will grow by 18.0% annually over 2021-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication. Highlighted with 39 tables and 77 figures, this 150-page report “Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country. Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Consumables • Software Based on Omics Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single Cell Genomics (SCG) • Single Cell Transcriptomics (SCT) • Single Cell Proteomics (SCP) • Single Cell Metabolomics (SCM) By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Clinical Research o Oncology o Cell Therapy o Immunology o Neurology o Cell Biology o Other Types of Clinical Research • Translation Research • Synthetic Biology By Sample Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Human Samples o Cancer Tissues o Stem Cells o Immune Cells o Brain Cells o Other Human Samples • Animal Samples • Microbial Samples By Workflow, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single-Cell Isolation and Dispensing o Fluorescence-Activated Cell Sorting (FACS) o Microfluidics o Magnetic-Activated Cell Sorting (MACS) o Random Seeding o Manual Cell Picking o Laser Capture Microdissection o Other Technologies of Single-Cell Isolation and Dispensing • Single-Cell Analysis o Polymerase Chain Reaction o Next-Generation Sequencing o Mass Cytometry o Mass Spectrometry o Other Technologies of Single-Cell Analysis By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Research and Academic Laboratories • Biopharmaceutical and Biotech Companies • Contract Research Organizations (CROs) • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: 10x Genomics, Inc. 1CellBio, Inc. Becton, Dickinson and Company Berkeley Lights, Inc. BGI Genomics Co., Ltd. Bio-Rad Laboratories, Inc. Bio-Techne Corporation BioTuring, Inc. Danaher Corporation (Cytiva Life Sciences) Dolomite Bio Fluidigm Corporation Fluxion Biosciences Illimina, Inc Mission Bio, Inc. Namocell, Inc. NanoString Technologies, Inc. Parse Biosciences, Inc. Proteona Qiagen N.V. RareCyte, Inc. Scipio Biosciences SAS Shilps Sciences Takara Bio Inc. (Takara Holdings) Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:
1 Introduction	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	25
2.2 Major Growth Drivers	27
2.3 Market Restraints and Challenges	35
2.4 Emerging Opportunities and Market Trends	38
2.5 Porter’s Fiver Forces Analysis	42
3 Segmentation of Europe Market by Product Type	46
3.1 Market Overview by Product Type	46
3.2 Instruments	48
3.3 Consumables	49
3.4 Software	50
4 Segmentation of Europe Market by Omics Type	51
4.1 Market Overview by Omics Type	51
4.2 Single Cell Genomics (SCG)	53
4.3 Single Cell Transcriptomics (SCT)	54
4.4 Single Cell Proteomics (SCP)	55
4.5 Single Cell Metabolomics (SCM)	56
5 Segmentation of Europe Market by Application	57
5.1 Market Overview by Application	57
5.2 Clinical Research	59
5.2.1 Oncology	61
5.2.2 Cell Therapy	62
5.2.3 Immunology	63
5.2.4 Neurology	64
5.2.5 Cell Biology	65
5.2.6 Other Types of Clinical Research	66
5.3 Translation Research	67
5.4 Synthetic Biology	68
6 Segmentation of Europe Market by Sample Type	69
6.1 Market Overview by Sample Type	69
6.2 Human Samples	71
6.2.1 Cancer Tissues	73
6.2.2 Stem Cells	74
6.2.3 Immune Cells	75
6.2.4 Brain Cells	76
6.2.5 Other Human Samples	77
6.3 Animal Samples	78
6.4 Microbial Samples	79
7 Segmentation of Europe Market by Workflow	80
7.1 Market Overview by Workflow	80
7.2 Single-Cell Isolation and Dispensing	82
7.2.1 Fluorescence-Activated Cell Sorting (FACS)	84
7.2.2 Microfluidics	85
7.2.3 Magnetic-Activated Cell Sorting (MACS)	86
7.2.4 Random Seeding	87
7.2.5 Manual Cell Picking	88
7.2.6 Laser Capture Microdissection	89
7.2.7 Other Technologies of Single-Cell Isolation and Dispensing	90
7.3 Single-Cell Analysis	91
7.3.1 Polymerase Chain Reaction	93
7.3.2 Next-Generation Sequencing	94
7.3.3 Mass Cytometry	95
7.3.4 Mass Spectrometry	96
7.3.5 Other Technologies of Single-Cell Analysis	97
8 Segmentation of Europe Market by End User	98
8.1 Market Overview by End User	98
8.2 Research and Academic Laboratories	100
8.3 Biopharmaceutical and Biotech Companies	101
8.4 Contract Research Organizations (CROs)	102
8.5 Other End Users	103
9 European Market 2021-2031 by Country	104
9.1 Overview of European Market	104
9.2 Germany	107
9.3 U.K.	109
9.4 France	111
9.5 Spain	113
9.6 Italy	115
9.7 Netherlands	117
9.8 Rest of European Market	119
10 Competitive Landscape	121
10.1 Overview of Key Vendors	121
10.2 New Product Launch, Partnership, Investment, and M&A	124
10.3 Company Profiles	125
10x Genomics, Inc.	125
1CellBio, Inc.	127
Becton, Dickinson and Company	128
Berkeley Lights, Inc.	129
BGI Genomics Co., Ltd.	130
Bio-Rad Laboratories, Inc.	131
Bio-Techne Corporation	132
BioTuring, Inc.	133
Danaher Corporation (Cytiva Life Sciences)	134
Dolomite Bio	135
Fluidigm Corporation	136
Fluxion Biosciences	137
Illimina, Inc	138
Mission Bio, Inc.	139
Namocell, Inc.	140
NanoString Technologies, Inc.	141
Parse Biosciences, Inc.	142
Proteona	143
Qiagen N.V.	144
RareCyte, Inc.	145
Scipio Biosciences SAS	146
Shilps Sciences	147
Takara Bio Inc. (Takara Holdings)	148
Thermo Fisher Scientific Inc.	149
RELATED REPORTS	150
List of Tables:


Table 1.  Snapshot of Europe Single Cell Multiomics Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. World Economic Outlook, 2021-2023	23
Table 4. Comparison of Rare Disease in Different Countries	32
Table 5. World Health Spending by Region, $ bn, 2013-2020	34
Table 6.  Main Product Trends and Market Opportunities in Europe Single Cell Multiomics Market	38
Table 7. Europe Single Cell Multiomics Market by Product Type, 2021-2031, $ mn	46
Table 8. Europe Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	51
Table 9. Europe Single Cell Multiomics Market by Application, 2021-2031, $ mn	57
Table 10. Europe Single Cell Multiomics Market: Clinical Research by Type, 2021-2031, $ mn	60
Table 11. Europe Single Cell Multiomics Market by Sample Type, 2021-2031, $ mn	69
Table 12. Europe Single Cell Multiomics Market: Human Samples by Type, 2021-2031, $ mn	72
Table 13. Europe Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	80
Table 14. Europe Single Cell Multiomics Market: Single-Cell Isolation and Dispensing by Technology, 2021-2031, $ mn	83
Table 15. Europe Single Cell Multiomics Market: Single-Cell Analysis by Technology, 2021-2031, $ mn	92
Table 16. Europe Single Cell Multiomics Market by End User, 2021-2031, $ mn	98
Table 17. Europe Single Cell Multiomics Market by Country, 2021-2031, $ mn	106
Table 18. Germany Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	108
Table 19. Germany Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	108
Table 20. Germany Single Cell Multiomics Market by End User, 2021-2031, $ mn	108
Table 21. U.K. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	110
Table 22. U.K. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	110
Table 23. U.K. Single Cell Multiomics Market by End User, 2021-2031, $ mn	110
Table 24. France Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	112
Table 25. France Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	112
Table 26. France Single Cell Multiomics Market by End User, 2021-2031, $ mn	112
Table 27. Spain Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	114
Table 28. Spain Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	114
Table 29. Spain Single Cell Multiomics Market by End User, 2021-2031, $ mn	114
Table 30. Italy Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	116
Table 31. Italy Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	116
Table 32. Italy Single Cell Multiomics Market by End User, 2021-2031, $ mn	116
Table 33. Netherlands Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	118
Table 34. Netherlands Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	118
Table 35. Netherlands Single Cell Multiomics Market by End User, 2021-2031, $ mn	118
Table 36. Single Cell Multiomics Market in Rest of Europe by Country, 2021-2031, $ mn	120
Table 37. 10x Genomics, Inc.: Company Snapshot	125
Table 38. 10x Genomics, Inc.: Business Segmentation	126
Table 39. 10x Genomics, Inc.: Product Portfolio	126
List of Figures:


Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. Europe Single Cell Multiomics Market, 2021-2031, $ mn	20
Figure 5. Impact of COVID-19 on Business	25
Figure 6. Primary Drivers and Impact Factors of Europe Single Cell Multiomics Market	27
Figure 7.  Leading Causes of Death in the World, 2000 and 2019, million	30
Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-2019	31
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	33
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	33
Figure 11. Primary Restraints and Impact Factors of Europe Single Cell Multiomics Market	35
Figure 12. Investment Opportunity Analysis	39
Figure 13. Porter’s Fiver Forces Analysis of Europe Single Cell Multiomics Market	42
Figure 14. Breakdown of Europe Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue	47
Figure 15. Europe Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%)	47
Figure 16. Europe Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn	48
Figure 17. Europe Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn	49
Figure 18. Europe Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn	50
Figure 19. Breakdown of Europe Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue	52
Figure 20. Europe Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%)	52
Figure 21. Europe Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn	53
Figure 22. Europe Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn	54
Figure 23. Europe Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn	55
Figure 24. Europe Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn	56
Figure 25. Breakdown of Europe Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue	58
Figure 26. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	58
Figure 27. Europe Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn	59
Figure 28. Europe Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn	61
Figure 29. Europe Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn	62
Figure 30. Europe Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn	63
Figure 31. Europe Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn	64
Figure 32. Europe Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn	65
Figure 33. Europe Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn	66
Figure 34. Europe Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn	67
Figure 35. Europe Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn	68
Figure 36. Breakdown of Europe Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue	70
Figure 37. Europe Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%)	70
Figure 38. Europe Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn	71
Figure 39. Europe Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn	73
Figure 40. Europe Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn	74
Figure 41. Europe Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn	75
Figure 42. Europe Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn	76
Figure 43. Europe Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn	77
Figure 44. Europe Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn	78
Figure 45. Europe Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn	79
Figure 46. Breakdown of Europe Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue	81
Figure 47. Europe Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%)	81
Figure 48. Europe Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn	82
Figure 49. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn	84
Figure 50. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn	85
Figure 51. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn	86
Figure 52. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn	87
Figure 53. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn	88
Figure 54. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn	89
Figure 55. Europe Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn	90
Figure 56. Europe Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn	91
Figure 57. Europe Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn	93
Figure 58. Europe Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn	94
Figure 59. Europe Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn	95
Figure 60. Europe Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn	96
Figure 61. Europe Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn	97
Figure 62. Breakdown of Europe Single Cell Multiomics Market by End User, 2021-2031, % of Revenue	98
Figure 63. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	99
Figure 64. Europe Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn	100
Figure 65. Europe Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn	101
Figure 66. Europe Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn	102
Figure 67. Europe Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn	103
Figure 68. Breakdown of European Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue	105
Figure 69. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	106
Figure 70.  Single Cell Multiomics Market in Germany, 2021-2031, $ mn	107
Figure 71.  Single Cell Multiomics Market in U.K., 2021-2031, $ mn	109
Figure 72.  Single Cell Multiomics Market in France, 2021-2031, $ mn	111
Figure 73.  Single Cell Multiomics Market in Spain, 2021-2031, $ mn	113
Figure 74.  Single Cell Multiomics Market in Italy, 2021-2031, $ mn	115
Figure 75.  Single Cell Multiomics Market in Netherlands, 2021-2031, $ mn	117
Figure 76.  Single Cell Multiomics Market in Rest of Europe, 2021-2031, $ mn	119
Figure 77. Growth Stage of Europe Single Cell Multiomics Industry over the Forecast Period	121
Selected Key Players: 
10x Genomics, Inc.
1CellBio, Inc.
Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)